Tissue damage of different submucosal injection solutions for EMR

Mitsuhiro Fujishiro, Naohisa Yahagi, Koji Kashimura, Toyokazu Matsuura, Masanori Nakamura, Naomi Kakushima, Shinya Kodashima, Satoshi Ono, Katsuya Kobayashi, Takuhei Hashimoto, Nobutake Yamamichi, Ayako Tateishi, Yasuhito Shimizu, Masashi Oka, Masao Ichinose, Masao Omata

Research output: Contribution to journalArticle

114 Citations (Scopus)

Abstract

Background: When choosing submucosal injection solutions for EMR, tissue damage should be considered, as well as the lesion-lifting ability. The objective of the study was to find out the potential tissue damage of submucosal injection solutions. Methods: The submucosal injection solutions examined were the following: normal saline solution (NS), 3.75% NaCl, 20% and 50% dextrose water (DW), a glycerin solution (Glyceol; 10% glycerin with 0.9% NaCl plus 5% fructose), and two hyaluronic acid (HA) solutions (0.25% 1900 kDa/NS solution and 0.125% 1900 kDa/ Glyceol solution). Furthermore, DW with different concentrations (5%, 10%, 15%, 30%, 40%) also was examined to find out the tolerable concentration without tissue damage. A total of 2 mL of each solution per stomach were injected by endoscopy into the submucosal layer at the separate sites of 4 living minipigs. Two minipigs were euthanized after 30 minutes of endoscopic observations, and the others were euthanized after additional endoscopic observations a week after injection. Results: There was no apparent tissue damage in NS, 5% and 10% DW, Glyceol, or two solutions of HA, whereas, hypertonic solutions, except Glyceol and 10% DW, have more or less potency of tissue damage. In 3.75% NaCl and DW with concentrations of ≥20%, considerable tissue damage was observed, which might affect resected EMR specimens and ulcer healing. Conclusions: Use of hypertonic solutions except Glyceol is not recommended with respect to tissue damage. A combination of HA and Glyceol is the most favorable submucosal injection solution, considering tissue damage and lesion-lifting ability.

Original languageEnglish
Pages (from-to)933-942
Number of pages10
JournalGastrointestinal Endoscopy
Volume62
Issue number6
DOIs
Publication statusPublished - 2005 Dec
Externally publishedYes

Fingerprint

Injections
Glucose
Hyaluronic Acid
Water
Sodium Chloride
Hypertonic Solutions
Miniature Swine
Glycerol
Fructose
Endoscopy
Ulcer
Stomach

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Fujishiro, M., Yahagi, N., Kashimura, K., Matsuura, T., Nakamura, M., Kakushima, N., ... Omata, M. (2005). Tissue damage of different submucosal injection solutions for EMR. Gastrointestinal Endoscopy, 62(6), 933-942. https://doi.org/10.1016/j.gie.2005.07.052

Tissue damage of different submucosal injection solutions for EMR. / Fujishiro, Mitsuhiro; Yahagi, Naohisa; Kashimura, Koji; Matsuura, Toyokazu; Nakamura, Masanori; Kakushima, Naomi; Kodashima, Shinya; Ono, Satoshi; Kobayashi, Katsuya; Hashimoto, Takuhei; Yamamichi, Nobutake; Tateishi, Ayako; Shimizu, Yasuhito; Oka, Masashi; Ichinose, Masao; Omata, Masao.

In: Gastrointestinal Endoscopy, Vol. 62, No. 6, 12.2005, p. 933-942.

Research output: Contribution to journalArticle

Fujishiro, M, Yahagi, N, Kashimura, K, Matsuura, T, Nakamura, M, Kakushima, N, Kodashima, S, Ono, S, Kobayashi, K, Hashimoto, T, Yamamichi, N, Tateishi, A, Shimizu, Y, Oka, M, Ichinose, M & Omata, M 2005, 'Tissue damage of different submucosal injection solutions for EMR', Gastrointestinal Endoscopy, vol. 62, no. 6, pp. 933-942. https://doi.org/10.1016/j.gie.2005.07.052
Fujishiro M, Yahagi N, Kashimura K, Matsuura T, Nakamura M, Kakushima N et al. Tissue damage of different submucosal injection solutions for EMR. Gastrointestinal Endoscopy. 2005 Dec;62(6):933-942. https://doi.org/10.1016/j.gie.2005.07.052
Fujishiro, Mitsuhiro ; Yahagi, Naohisa ; Kashimura, Koji ; Matsuura, Toyokazu ; Nakamura, Masanori ; Kakushima, Naomi ; Kodashima, Shinya ; Ono, Satoshi ; Kobayashi, Katsuya ; Hashimoto, Takuhei ; Yamamichi, Nobutake ; Tateishi, Ayako ; Shimizu, Yasuhito ; Oka, Masashi ; Ichinose, Masao ; Omata, Masao. / Tissue damage of different submucosal injection solutions for EMR. In: Gastrointestinal Endoscopy. 2005 ; Vol. 62, No. 6. pp. 933-942.
@article{8081b55615d8436294422eeebd3b03db,
title = "Tissue damage of different submucosal injection solutions for EMR",
abstract = "Background: When choosing submucosal injection solutions for EMR, tissue damage should be considered, as well as the lesion-lifting ability. The objective of the study was to find out the potential tissue damage of submucosal injection solutions. Methods: The submucosal injection solutions examined were the following: normal saline solution (NS), 3.75{\%} NaCl, 20{\%} and 50{\%} dextrose water (DW), a glycerin solution (Glyceol; 10{\%} glycerin with 0.9{\%} NaCl plus 5{\%} fructose), and two hyaluronic acid (HA) solutions (0.25{\%} 1900 kDa/NS solution and 0.125{\%} 1900 kDa/ Glyceol solution). Furthermore, DW with different concentrations (5{\%}, 10{\%}, 15{\%}, 30{\%}, 40{\%}) also was examined to find out the tolerable concentration without tissue damage. A total of 2 mL of each solution per stomach were injected by endoscopy into the submucosal layer at the separate sites of 4 living minipigs. Two minipigs were euthanized after 30 minutes of endoscopic observations, and the others were euthanized after additional endoscopic observations a week after injection. Results: There was no apparent tissue damage in NS, 5{\%} and 10{\%} DW, Glyceol, or two solutions of HA, whereas, hypertonic solutions, except Glyceol and 10{\%} DW, have more or less potency of tissue damage. In 3.75{\%} NaCl and DW with concentrations of ≥20{\%}, considerable tissue damage was observed, which might affect resected EMR specimens and ulcer healing. Conclusions: Use of hypertonic solutions except Glyceol is not recommended with respect to tissue damage. A combination of HA and Glyceol is the most favorable submucosal injection solution, considering tissue damage and lesion-lifting ability.",
author = "Mitsuhiro Fujishiro and Naohisa Yahagi and Koji Kashimura and Toyokazu Matsuura and Masanori Nakamura and Naomi Kakushima and Shinya Kodashima and Satoshi Ono and Katsuya Kobayashi and Takuhei Hashimoto and Nobutake Yamamichi and Ayako Tateishi and Yasuhito Shimizu and Masashi Oka and Masao Ichinose and Masao Omata",
year = "2005",
month = "12",
doi = "10.1016/j.gie.2005.07.052",
language = "English",
volume = "62",
pages = "933--942",
journal = "Gastrointestinal Endoscopy",
issn = "0016-5107",
publisher = "Mosby Inc.",
number = "6",

}

TY - JOUR

T1 - Tissue damage of different submucosal injection solutions for EMR

AU - Fujishiro, Mitsuhiro

AU - Yahagi, Naohisa

AU - Kashimura, Koji

AU - Matsuura, Toyokazu

AU - Nakamura, Masanori

AU - Kakushima, Naomi

AU - Kodashima, Shinya

AU - Ono, Satoshi

AU - Kobayashi, Katsuya

AU - Hashimoto, Takuhei

AU - Yamamichi, Nobutake

AU - Tateishi, Ayako

AU - Shimizu, Yasuhito

AU - Oka, Masashi

AU - Ichinose, Masao

AU - Omata, Masao

PY - 2005/12

Y1 - 2005/12

N2 - Background: When choosing submucosal injection solutions for EMR, tissue damage should be considered, as well as the lesion-lifting ability. The objective of the study was to find out the potential tissue damage of submucosal injection solutions. Methods: The submucosal injection solutions examined were the following: normal saline solution (NS), 3.75% NaCl, 20% and 50% dextrose water (DW), a glycerin solution (Glyceol; 10% glycerin with 0.9% NaCl plus 5% fructose), and two hyaluronic acid (HA) solutions (0.25% 1900 kDa/NS solution and 0.125% 1900 kDa/ Glyceol solution). Furthermore, DW with different concentrations (5%, 10%, 15%, 30%, 40%) also was examined to find out the tolerable concentration without tissue damage. A total of 2 mL of each solution per stomach were injected by endoscopy into the submucosal layer at the separate sites of 4 living minipigs. Two minipigs were euthanized after 30 minutes of endoscopic observations, and the others were euthanized after additional endoscopic observations a week after injection. Results: There was no apparent tissue damage in NS, 5% and 10% DW, Glyceol, or two solutions of HA, whereas, hypertonic solutions, except Glyceol and 10% DW, have more or less potency of tissue damage. In 3.75% NaCl and DW with concentrations of ≥20%, considerable tissue damage was observed, which might affect resected EMR specimens and ulcer healing. Conclusions: Use of hypertonic solutions except Glyceol is not recommended with respect to tissue damage. A combination of HA and Glyceol is the most favorable submucosal injection solution, considering tissue damage and lesion-lifting ability.

AB - Background: When choosing submucosal injection solutions for EMR, tissue damage should be considered, as well as the lesion-lifting ability. The objective of the study was to find out the potential tissue damage of submucosal injection solutions. Methods: The submucosal injection solutions examined were the following: normal saline solution (NS), 3.75% NaCl, 20% and 50% dextrose water (DW), a glycerin solution (Glyceol; 10% glycerin with 0.9% NaCl plus 5% fructose), and two hyaluronic acid (HA) solutions (0.25% 1900 kDa/NS solution and 0.125% 1900 kDa/ Glyceol solution). Furthermore, DW with different concentrations (5%, 10%, 15%, 30%, 40%) also was examined to find out the tolerable concentration without tissue damage. A total of 2 mL of each solution per stomach were injected by endoscopy into the submucosal layer at the separate sites of 4 living minipigs. Two minipigs were euthanized after 30 minutes of endoscopic observations, and the others were euthanized after additional endoscopic observations a week after injection. Results: There was no apparent tissue damage in NS, 5% and 10% DW, Glyceol, or two solutions of HA, whereas, hypertonic solutions, except Glyceol and 10% DW, have more or less potency of tissue damage. In 3.75% NaCl and DW with concentrations of ≥20%, considerable tissue damage was observed, which might affect resected EMR specimens and ulcer healing. Conclusions: Use of hypertonic solutions except Glyceol is not recommended with respect to tissue damage. A combination of HA and Glyceol is the most favorable submucosal injection solution, considering tissue damage and lesion-lifting ability.

UR - http://www.scopus.com/inward/record.url?scp=27844475653&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=27844475653&partnerID=8YFLogxK

U2 - 10.1016/j.gie.2005.07.052

DO - 10.1016/j.gie.2005.07.052

M3 - Article

C2 - 16301040

AN - SCOPUS:27844475653

VL - 62

SP - 933

EP - 942

JO - Gastrointestinal Endoscopy

JF - Gastrointestinal Endoscopy

SN - 0016-5107

IS - 6

ER -